Showing results (71-80 of 375) with videos related to
Sort By:
Pageof 38
Frontiers in Bioscience (Landmark Edition)|October 6, 2019
Iodothyronine deiodinases and reduced sensitivity to thyroid hormonesRosa Maria Paragliola, Andrea Corsello, Paola Concolino, et al.Reviews in Endocrine & Metabolic Disorders|October 21, 2016
Adrenal disorders: Is there Any role for vitamin D?Giacomo Tirabassi, Gianmaria Salvio, Barbara Altieri, et al.Endocrine|July 11, 2016
Factors predicting the duration of adrenal insufficiency in patients successfully treated for Cushing disease and nonmalignant primary adrenal Cushing syndromeAlessandro Prete, Rosa Maria Paragliola, Filomena Bottiglieri, et al.Frontiers in Endocrinology|February 18, 2021
Switching From Immediate-Release to Fractionated Dual-Release Hydrocortisone May Improve Metabolic Control and QoL in Selected Primary Adrenal Insufficiency PatientsFrancesca Delle Cese, Andrea Corsello, Marco Cintoni, et al.Molecular Cancer Therapeutics|March 31, 2012
IGF-1R/MDM2 relationship confers enhanced sensitivity to RITA in Ewing sarcoma cellsGiusy Di Conza, Marianna Buttarelli, Olimpia Monti, et al.The Journal of Clinical Endocrinology and Metabolism|February 4, 2014
Cushing's syndrome due to a bronchial ACTH-secreting carcinoid successfully treated with radiofrequency ablation (RFA)Salvatore M Corsello, Paola Senes, Roberto Iezzi, et al.Molecular Biology Reports|August 19, 2020
A novel MEN1 pathogenic variant in an Italian patient with multiple endocrine neoplasia type 1Andrea Corsello, Carmine Bruno, Roberta Rizza, et al.Advances in Urology|September 15, 2011
Biochemical alterations in semen of varicocele patients: a review of the literatureAntonio Mancini, Roberto Festa, Sebastiano Raimondo, et al.Diseases (Basel, Switzerland)|January 24, 2025
Hypercalcemia Following Adrenalectomy for Cushing Syndrome in a Patient with Post-Surgical HypoparathyroidismPietro Locantore, Alessandro Oliva, Gianluca Cera, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|July 10, 2024
The Role of the GH Receptor Polymorphisms as a Prognostic Factor of Vertebral Fractures in Acromegalic Patients Resistant to First-generation SSAs and Treated with Pegvisomant or Pasireotide LARFlavia Costanza, Sabrina Chiloiro, Antonella Giampietro, et al.Pageof 38